• Country
    Clear
  • Type
  • Compatibility Level
  • Thematic
  • Jurisdiction
6,321 Data sources

  • GB
  • NL
  • IT
  • SG
  • BE
  • AT

  • A database containing genome size (C-value) data for all groups of land plants and red, green and brown algae.

    more_vert
  • more_vert
  • Open Access repository of INFN publications and data, to be eventually extended to other organisations. The interface is in English.

    more_vert
  • This site provides access to the research output of the institution. Users may set up RSS feeds to be alerted to new content. The interface is in English. Some items are not available as full text.

    more_vert
  • The Database of Protein Disorder (DisProt) is a curated database that provides information about intrinsically disordered proteins that lack fixed 3D structure in their putatively native states, either in their entirety or in part. Disordered regions are manually curated from literature. DisProt annotations cover both structural and functional aspects of disorder detected by specific experimental methods.

    more_vert
  • BuG@Sbase is a microbial gene expression and comparative genomic database containing microarray datasets.

    more_vert
  • This site provides access to the research output of the institution. Some items are not available as full text. The interface in French and English

    more_vert
  • more_vert
  • University of Groningen institutional repository

    more_vert
  • Nearly 60% of patients undergoing cancer treatment are estimated to have had at least one potential drug-drug interaction; for patients receiving oral anticancer therapy, up to 50% have been reported to experience a potential drug-drug interaction, with 16% experiencing a major event. Drug-drug interactions are therefore a significant issue for cancer patients and the health care professionals who treat them. Combining the internationally recognised drug-drug interactions expertise of the University of Liverpool (UK) with the clinical pharmacology in oncology and haemotology expertise of Radboud University, Nijmegen (the Netherlands), this site was established in 2017 in response to the need for improved management of DDIs with anti-cancer agents.

    more_vert
  • chevron_left
  • 6
  • 7
  • 8
  • 9
  • 10
  • chevron_right
6,321 Data sources
  • A database containing genome size (C-value) data for all groups of land plants and red, green and brown algae.

    more_vert
  • more_vert
  • Open Access repository of INFN publications and data, to be eventually extended to other organisations. The interface is in English.

    more_vert
  • This site provides access to the research output of the institution. Users may set up RSS feeds to be alerted to new content. The interface is in English. Some items are not available as full text.

    more_vert
  • The Database of Protein Disorder (DisProt) is a curated database that provides information about intrinsically disordered proteins that lack fixed 3D structure in their putatively native states, either in their entirety or in part. Disordered regions are manually curated from literature. DisProt annotations cover both structural and functional aspects of disorder detected by specific experimental methods.

    more_vert
  • BuG@Sbase is a microbial gene expression and comparative genomic database containing microarray datasets.

    more_vert
  • This site provides access to the research output of the institution. Some items are not available as full text. The interface in French and English

    more_vert
  • more_vert
  • University of Groningen institutional repository

    more_vert
  • Nearly 60% of patients undergoing cancer treatment are estimated to have had at least one potential drug-drug interaction; for patients receiving oral anticancer therapy, up to 50% have been reported to experience a potential drug-drug interaction, with 16% experiencing a major event. Drug-drug interactions are therefore a significant issue for cancer patients and the health care professionals who treat them. Combining the internationally recognised drug-drug interactions expertise of the University of Liverpool (UK) with the clinical pharmacology in oncology and haemotology expertise of Radboud University, Nijmegen (the Netherlands), this site was established in 2017 in response to the need for improved management of DDIs with anti-cancer agents.

    more_vert
  • chevron_left
  • 6
  • 7
  • 8
  • 9
  • 10
  • chevron_right